Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
EN
/
CN
Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
Issue 12: Quick Overview of NMPA/CDE Regulations for May-June
Release time：2026-07-08
share:
Previous article：That's not it.....
next article：Issue 11: Key Updates in Medical and Pharmaceutical Regulations for Early to Mid-2026
Back to list
You may also want to read
Hefei Leecan Pharmaceutical welcomes daily supervision and inspection by the First Branch of Anhui Provincial Drug Administration
2025.06.25
Xu Bin, Secretary of the Party Group and Director of the Hefei Municipal Bureau of Industry and Information Technology, and his delegation visited Leecan for inspection and research
2024.10.17
Obtaining drug production approval for inhalation of compound ipratropium bromide solution!
2025.01.06
